Molly Grammel

Federal Circuit Denies Injunction Pending Appeal After Amgen Beat Preliminary Injunction For Biosimilar Aflibercept

Recent PTAB Developments For Regeneron's Aflibercept-Dosing Patents

Celltrion Launches 80 Mg YUFLYMA (Adalimumab-aaty) In The U.S.

Regeneron Sues Celltrion For Proposed Biosimilar Of Eylea In West Virginia District Court

Formycon And Celltrion Announce FDA Submission Of ABLAs Seeking Approval To Market Aflibercept Biosimilars

Regeneron Files Expedited Motion Challenging Mylan's Designation Of Entire ABLA Production As Outside Counsel's Eyes Only

Regeneron Files First BPCIA Complaint Regarding Biosimilar Eylea Against Mylan In West Virginia District Court

CA Gov. Newsom Announces Budget Approval For Biosimilar Insulin Initiative